BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pi M, Kuang H, Yue C, Yang Q, Wu A, Li Y, Assaraf YG, Yang D, Wu S. Targeting metabolism to overcome cancer drug resistance: A promising therapeutic strategy for diffuse large B cell lymphoma. Drug Resistance Updates 2022;61:100822. [DOI: 10.1016/j.drup.2022.100822] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Lou X, Zhao K, Xu J, Shuai L, Niu H, Cao Z, Wang J, Zhang Y. CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma via M2 macrophage interactions: A bioinformatic analysis of the tumor microenvironment. Front Immunol 2022;13:950213. [DOI: 10.3389/fimmu.2022.950213] [Reference Citation Analysis]
2 Tang Y, Zhang Z, Chen Y, Qin S, Zhou L, Gao W, Shen Z. Metabolic Adaptation-Mediated Cancer Survival and Progression in Oxidative Stress. Antioxidants 2022;11:1324. [DOI: 10.3390/antiox11071324] [Reference Citation Analysis]
3 Huang M, Lin Y, Wang C, Deng L, Chen M, Assaraf YG, Chen ZS, Ye W, Zhang D. New insights into antiangiogenic therapy resistance in cancer: Mechanisms and therapeutic aspects. Drug Resist Updat 2022;64:100849. [PMID: 35842983 DOI: 10.1016/j.drup.2022.100849] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Lu J, Liu P, Zhang R. A Metabolic Gene Signature to Predict Breast Cancer Prognosis. Front Mol Biosci 2022;9:900433. [DOI: 10.3389/fmolb.2022.900433] [Reference Citation Analysis]